A pilot study of patient reported outcomes evaluating treatment related symptoms and quality of life for men receiving high dose rate brachytherapy combined with hypo-fractionated radiotherapy or hypo-fractionated radiotherapy alone for the treatment of localised prostate cancer

Autor: Crowther, Karen, Cole, Aidan, Shiels, Pat, Jain, Suneil, Shepherd, Paul, Mitchell, Darren
Zdroj: Technical Innovations & Patient Support in Radiation Oncology; March 2019, Vol. 9 Issue: 1 p18-25, 8p
Abstrakt: •PROMs have an important role to play in clinical practice.•The radiographer-led collection of multiple PROMs is feasible.•Monotherapy Group reported higher levels of bowel toxicity than Combination Group.•RTOG scale was not of sufficient sensitivity and under-reported symptoms.•A good QoL was maintained throughout treatment for both treatment groups.
Databáze: Supplemental Index